25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

000513 (Livzon) Stock Analysis
Buy, Hold or Sell?

Let's analyze Livzon together

I guess you are interested in Livzon Pharmaceutical Group Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Livzon’s Financial Insights
  • 📈 Technical Analysis (TA) – Livzon’s Price Targets

I'm going to help you getting a better view of Livzon Pharmaceutical Group Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Livzon Pharmaceutical Group Inc

I send you an email if I find something interesting about Livzon Pharmaceutical Group Inc.

1. Quick Overview

1.1. Quick analysis of Livzon (30 sec.)










1.2. What can you expect buying and holding a share of Livzon? (30 sec.)

How much money do you get?

How much money do you get?
¥0.20
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥16.87
Expected worth in 1 year
¥17.23
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
¥1.80
Return On Investment
5.0%

For what price can you sell your share?

Current Price per Share
¥36.04
Expected price per share
¥30.87 - ¥38.03
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Livzon (5 min.)




Live pricePrice per Share (EOD)
¥36.04
Intrinsic Value Per Share
¥17.90 - ¥32.50
Total Value Per Share
¥34.77 - ¥49.37

2.2. Growth of Livzon (5 min.)




Is Livzon growing?

Current yearPrevious yearGrowGrow %
How rich?$2.1b$2b$21.9m1.1%

How much money is Livzon making?

Current yearPrevious yearGrowGrow %
Making money$72.8m$68.9m$3.8m5.3%
Net Profit Margin17.7%16.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Livzon (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Livzon?

Welcome investor! Livzon's management wants to use your money to grow the business. In return you get a share of Livzon.

First you should know what it really means to hold a share of Livzon. And how you can make/lose money.

Speculation

The Price per Share of Livzon is ¥36.04. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Livzon.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Livzon, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥16.87. Based on the TTM, the Book Value Change Per Share is ¥0.09 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.36 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Livzon.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.100.3%0.080.2%0.070.2%0.080.2%0.070.2%0.070.2%
Usd Book Value Change Per Share0.070.2%0.010.0%0.000.0%0.010.0%0.020.1%0.040.1%
Usd Dividend Per Share0.000.0%0.050.1%0.060.2%0.050.1%0.050.1%0.040.1%
Usd Total Gains Per Share0.070.2%0.060.2%0.060.2%0.060.2%0.070.2%0.080.2%
Usd Price Per Share4.95-5.27-5.14-5.05-5.45-6.10-
Price to Earnings Ratio12.70-17.26-17.96-16.80-19.48-33.79-
Price-to-Total Gains Ratio67.07-33.83-18.09-42.67-60.87-92.02-
Price to Book Ratio2.10-2.33-2.32-2.27-2.55-4.14-
Price-to-Total Gains Ratio67.07-33.83-18.09-42.67-60.87-92.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.023976
Number of shares199
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.05
Usd Book Value Change Per Share0.010.02
Usd Total Gains Per Share0.060.07
Gains per Quarter (199 shares)12.4614.15
Gains per Year (199 shares)49.8356.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1401040391747
28020907934104
31203014011852161
41594019015769218
51995024019786275
623960290236103332
727970340276121389
831980390315138446
935990440354155503
10398100490394172560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%90.03.00.096.8%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%31.09.00.077.5%73.020.00.078.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.01.097.5%71.00.022.076.3%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%35.05.00.087.5%82.011.00.088.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Livzon Pharmaceutical Group Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5150.090+472%0.001+74120%0.079+551%0.155+232%0.287+79%
Book Value Per Share--16.87116.279+4%15.900+6%15.967+6%15.453+9%12.698+33%
Current Ratio--2.2762.019+13%2.175+5%2.170+5%2.247+1%2.150+6%
Debt To Asset Ratio--0.3720.398-7%0.412-10%0.401-7%0.377-1%0.357+4%
Debt To Equity Ratio--0.6430.706-9%0.748-14%0.718-10%0.662-3%0.618+4%
Dividend Per Share--0.0140.359-96%0.424-97%0.379-96%0.355-96%0.269-95%
Enterprise Value--23224576172.23024874694151.860-7%34900050850.510-33%30744465228.890-24%35552587716.792-35%39904513455.695-42%
Eps--0.6990.569+23%0.531+32%0.555+26%0.528+32%0.493+42%
Ev To Sales Ratio--1.8262.132-14%2.865-36%2.531-28%2.994-39%4.191-56%
Free Cash Flow Per Share--0.6420.605+6%0.818-21%0.606+6%0.488+32%0.441+46%
Free Cash Flow To Equity Per Share--0.6420.605+6%0.258+149%0.377+70%0.354+81%0.404+59%
Gross Profit Margin--1.0001.0000%-0.824+182%-0.263+126%-0.598+160%-1.414+241%
Intrinsic Value_10Y_max--32.496----------
Intrinsic Value_10Y_min--17.896----------
Intrinsic Value_1Y_max--2.548----------
Intrinsic Value_1Y_min--1.780----------
Intrinsic Value_3Y_max--8.195----------
Intrinsic Value_3Y_min--5.391----------
Intrinsic Value_5Y_max--14.493----------
Intrinsic Value_5Y_min--9.022----------
Market Cap21778719431.680-48%32334546500.40034775226343.623-7%34292877166.760-6%33641352613.978-4%36447683980.750-11%40022038033.160-19%
Net Profit Margin--0.2000.177+13%0.161+25%0.164+22%0.160+25%0.177+13%
Operating Margin----0%0.189-100%0.126-100%0.161-100%0.202-100%
Operating Ratio--1.0661.096-3%0.823+29%0.914+17%0.869+23%0.864+23%
Pb Ratio2.136+2%2.1032.327-10%2.322-9%2.272-7%2.553-18%4.135-49%
Pe Ratio12.896+2%12.69617.264-26%17.960-29%16.803-24%19.481-35%33.794-62%
Price Per Share36.040+2%35.48037.835-6%36.840-4%36.239-2%39.094-9%43.756-19%
Price To Free Cash Flow Ratio14.028+2%13.81015.778-12%11.351+22%19.408-29%17.369-20%90.306-85%
Price To Total Gains Ratio68.130+2%67.07133.831+98%18.087+271%42.673+57%60.872+10%92.016-27%
Quick Ratio--0.2860.262+9%1.900-85%1.401-80%1.690-83%1.725-83%
Return On Assets--0.0260.021+24%0.020+33%0.020+29%0.021+24%0.025+3%
Return On Equity--0.0450.037+21%0.036+27%0.036+24%0.037+23%0.042+7%
Total Gains Per Share--0.5290.449+18%0.425+24%0.458+16%0.510+4%0.556-5%
Usd Book Value--2143317030.5262084874650.123+3%2062898225.647+4%2066238895.864+4%2007187223.012+7%1637184796.037+31%
Usd Book Value Change Per Share--0.0720.013+472%0.000+74120%0.011+551%0.022+232%0.040+79%
Usd Book Value Per Share--2.3522.269+4%2.216+6%2.226+6%2.154+9%1.770+33%
Usd Dividend Per Share--0.0020.050-96%0.059-97%0.053-96%0.049-96%0.037-95%
Usd Enterprise Value--3237505918.4093467532364.769-7%4865067088.561-33%4285778452.907-24%4956030727.721-35%5562689175.724-42%
Usd Eps--0.0970.079+23%0.074+32%0.077+26%0.074+32%0.069+42%
Usd Free Cash Flow--81595386.94977555162.267+5%106074349.036-23%78365407.643+4%63331420.770+29%56444882.110+45%
Usd Free Cash Flow Per Share--0.0900.084+6%0.114-21%0.084+6%0.068+32%0.061+46%
Usd Free Cash Flow To Equity Per Share--0.0900.084+6%0.036+149%0.053+70%0.049+81%0.056+59%
Usd Market Cap3035953488.776-48%4507435782.1564847666552.301-7%4780427077.046-6%4689604554.388-4%5080807146.917-11%5579072101.822-19%
Usd Price Per Share5.024+2%4.9465.274-6%5.135-4%5.052-2%5.450-9%6.100-19%
Usd Profit--88757085.66472835800.425+22%68987851.019+29%69787734.086+27%67275002.097+32%63041973.681+41%
Usd Revenue--443368335.344409490007.118+8%425977851.507+4%424436518.198+4%418865174.645+6%355804124.242+25%
Usd Total Gains Per Share--0.0740.063+18%0.059+24%0.064+16%0.071+4%0.078-5%
 EOD+2 -6MRQTTM+29 -8YOY+24 -153Y+28 -115Y+28 -1110Y+23 -16

3.3 Fundamental Score

Let's check the fundamental score of Livzon Pharmaceutical Group Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.896
Price to Book Ratio (EOD)Between0-12.136
Net Profit Margin (MRQ)Greater than00.200
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.286
Current Ratio (MRQ)Greater than12.276
Debt to Asset Ratio (MRQ)Less than10.372
Debt to Equity Ratio (MRQ)Less than10.643
Return on Equity (MRQ)Greater than0.150.045
Return on Assets (MRQ)Greater than0.050.026
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Livzon Pharmaceutical Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.168
Ma 20Greater thanMa 5033.680
Ma 50Greater thanMa 10030.339
Ma 100Greater thanMa 20029.201
OpenGreater thanClose36.340
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Livzon Pharmaceutical Group Inc

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers drug preparation products, including Ilaprazole enteric coated tablets to treat duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection to treat endometriosis, hysteromyoma, premenopausal breast and prostate cancer, and central precocious puberty; and Urofollitropin for injection to treat anovulation and sufferers. It also provides Perospirone hydrochloride tablets to treat schizophrenia; Shenqi Fuzheng Injection to treat weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for treating lung and stomach cancer; anti-viral granules used for clearing heat, eliminating dampness, cooling blood, and detoxifying to treat upper respiratory tract infection and influenza; Tocilizumab injection to treat rheumatoid arthritis; and Recombinant SARSCoV-2 fusion protein vaccine used to prevent diseases caused by SARS-CoV-2 infection. In addition, the company offers antinuclear antibody test kit, used for the detection of common anti-nuclear and anti-antibodies in the autoimmune diseases; nucleic acid test kits for human immunodeficiency virus type 1; interferon-gamma release assays test kits, used to determine whether the human body is infected with Mycobacterium tuberculosis; diagnostic kit for IgM antibody to mycoplasma pneumonia. Further, it provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. Livzon Pharmaceutical Group Inc. was founded in 1985 and is headquartered in Zhuhai, China.

Fundamental data was last updated by Penke on 2025-06-21 12:44:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Livzon earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Livzon to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 20.0% means that ¥0.20 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Livzon Pharmaceutical Group Inc:

  • The MRQ is 20.0%. The company is making a huge profit. +2
  • The TTM is 17.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.0%TTM17.7%+2.3%
TTM17.7%YOY16.1%+1.6%
TTM17.7%5Y16.0%+1.6%
5Y16.0%10Y17.7%-1.6%
4.3.1.2. Return on Assets

Shows how efficient Livzon is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Livzon to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.6% Return on Assets means that Livzon generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Livzon Pharmaceutical Group Inc:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.1%+0.5%
TTM2.1%YOY2.0%+0.1%
TTM2.1%5Y2.1%+0.0%
5Y2.1%10Y2.5%-0.4%
4.3.1.3. Return on Equity

Shows how efficient Livzon is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Livzon to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.5% Return on Equity means Livzon generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Livzon Pharmaceutical Group Inc:

  • The MRQ is 4.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.5%TTM3.7%+0.8%
TTM3.7%YOY3.6%+0.2%
TTM3.7%5Y3.7%+0.1%
5Y3.7%10Y4.2%-0.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Livzon Pharmaceutical Group Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Livzon is operating .

  • Measures how much profit Livzon makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Livzon to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Livzon Pharmaceutical Group Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY18.9%-18.9%
TTM-5Y16.1%-16.1%
5Y16.1%10Y20.2%-4.1%
4.3.2.2. Operating Ratio

Measures how efficient Livzon is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.07 means that the operating costs are ¥1.07 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Livzon Pharmaceutical Group Inc:

  • The MRQ is 1.066. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.096. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.066TTM1.096-0.030
TTM1.096YOY0.823+0.272
TTM1.0965Y0.869+0.227
5Y0.86910Y0.864+0.005
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Livzon Pharmaceutical Group Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Livzon is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.28 means the company has ¥2.28 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Livzon Pharmaceutical Group Inc:

  • The MRQ is 2.276. The company is able to pay all its short-term debts. +1
  • The TTM is 2.019. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.276TTM2.019+0.256
TTM2.019YOY2.175-0.155
TTM2.0195Y2.247-0.228
5Y2.24710Y2.150+0.097
4.4.3.2. Quick Ratio

Measures if Livzon is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Livzon to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.29 means the company can pay off ¥0.29 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Livzon Pharmaceutical Group Inc:

  • The MRQ is 0.286. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.262. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.286TTM0.262+0.024
TTM0.262YOY1.900-1.638
TTM0.2625Y1.690-1.428
5Y1.69010Y1.725-0.035
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Livzon Pharmaceutical Group Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Livzon assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Livzon to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.37 means that Livzon assets are financed with 37.2% credit (debt) and the remaining percentage (100% - 37.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Livzon Pharmaceutical Group Inc:

  • The MRQ is 0.372. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.398. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.372TTM0.398-0.026
TTM0.398YOY0.412-0.014
TTM0.3985Y0.377+0.021
5Y0.37710Y0.357+0.019
4.5.4.2. Debt to Equity Ratio

Measures if Livzon is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Livzon to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 64.3% means that company has ¥0.64 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Livzon Pharmaceutical Group Inc:

  • The MRQ is 0.643. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.706. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.643TTM0.706-0.063
TTM0.706YOY0.748-0.042
TTM0.7065Y0.662+0.044
5Y0.66210Y0.618+0.044
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Livzon generates.

  • Above 15 is considered overpriced but always compare Livzon to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 12.70 means the investor is paying ¥12.70 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Livzon Pharmaceutical Group Inc:

  • The EOD is 12.896. Based on the earnings, the company is underpriced. +1
  • The MRQ is 12.696. Based on the earnings, the company is underpriced. +1
  • The TTM is 17.264. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD12.896MRQ12.696+0.200
MRQ12.696TTM17.264-4.569
TTM17.264YOY17.960-0.695
TTM17.2645Y19.481-2.217
5Y19.48110Y33.794-14.313
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Livzon Pharmaceutical Group Inc:

  • The EOD is 14.028. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.810. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 15.778. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD14.028MRQ13.810+0.218
MRQ13.810TTM15.778-1.967
TTM15.778YOY11.351+4.426
TTM15.7785Y17.369-1.591
5Y17.36910Y90.306-72.937
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Livzon is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Livzon Pharmaceutical Group Inc:

  • The EOD is 2.136. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.103. Based on the equity, the company is underpriced. +1
  • The TTM is 2.327. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.136MRQ2.103+0.033
MRQ2.103TTM2.327-0.224
TTM2.327YOY2.322+0.005
TTM2.3275Y2.553-0.226
5Y2.55310Y4.135-1.583
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets24,485,272
Total Liabilities9,109,970
Total Stockholder Equity14,165,649
 As reported
Total Liabilities 9,109,970
Total Stockholder Equity+ 14,165,649
Total Assets = 24,485,272

Assets

Total Assets24,485,272
Total Current Assets16,465,642
Long-term Assets8,019,630
Total Current Assets
Cash And Cash Equivalents 10,830,774
Short-term Investments 68,320
Net Receivables 2,001,140
Inventory 1,900,256
Other Current Assets 166,931
Total Current Assets  (as reported)16,465,642
Total Current Assets  (calculated)14,967,421
+/- 1,498,220
Long-term Assets
Property Plant Equipment 4,516,793
Goodwill 124,911
Intangible Assets 644,093
Long-term Assets Other 576,489
Long-term Assets  (as reported)8,019,630
Long-term Assets  (calculated)5,862,286
+/- 2,157,344

Liabilities & Shareholders' Equity

Total Current Liabilities7,235,300
Long-term Liabilities1,874,671
Total Stockholder Equity14,165,649
Total Current Liabilities
Short Long Term Debt 2,325,000
Accounts payable 1,538,918
Other Current Liabilities 3,642
Total Current Liabilities  (as reported)7,235,300
Total Current Liabilities  (calculated)3,867,560
+/- 3,367,740
Long-term Liabilities
Long term Debt 1,432,682
Capital Lease Obligations Min Short Term Debt14,723
Long-term Liabilities  (as reported)1,874,671
Long-term Liabilities  (calculated)1,447,404
+/- 427,266
Total Stockholder Equity
Retained Earnings 12,398,087
Total Stockholder Equity (as reported)14,165,649
Total Stockholder Equity (calculated)12,398,087
+/- 1,767,562
Other
Capital Stock911,346
Common Stock Shares Outstanding 911,346
Net Invested Capital 17,923,331
Net Working Capital 9,230,342
Property Plant and Equipment Gross 4,516,793



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-301999-12-311999-06-301998-12-311998-06-301997-12-311997-06-301996-12-311996-06-301995-12-311995-06-301994-12-311994-06-30
> Total Assets 
812,789
870,122
1,070,857
1,109,810
1,105,246
1,316,718
1,385,581
1,510,124
1,501,583
1,560,922
1,631,729
1,557,848
1,648,001
1,588,291
1,633,247
1,676,191
1,791,122
1,925,661
1,964,376
1,856,439
1,856,110
1,771,608
1,779,946
2,129,253
1,859,174
2,189,081
2,017,297
2,201,893
2,118,523
2,094,176
2,134,278
2,163,635
2,285,748
2,511,584
2,465,456
2,458,399
2,665,012
2,733,979
2,947,026
2,945,723
3,000,772
3,028,668
2,981,985
2,923,813
2,805,798
2,871,725
2,979,591
3,124,377
3,186,768
3,374,130
3,579,167
3,661,992
3,855,914
4,175,630
4,307,154
4,602,909
4,554,878
4,659,333
5,463,603
5,633,754
5,959,089
6,643,981
6,508,787
6,566,006
7,131,953
7,145,025
7,549,068
7,302,605
7,681,048
7,939,245
7,878,268
8,077,538
8,235,175
8,632,496
10,410,662
10,529,263
11,334,271
15,538,115
15,793,352
15,897,731
16,156,947
15,464,421
15,622,702
17,437,347
16,442,341
16,877,654
16,331,288
17,976,463
17,578,043
17,251,824
19,320,211
20,590,816
21,358,887
21,058,831
21,688,941
22,371,916
23,729,888
22,937,729
23,569,873
24,864,825
25,620,821
25,726,127
24,799,963
25,044,827
25,189,696
25,575,960
24,909,308
24,455,826
24,485,272
24,485,27224,455,82624,909,30825,575,96025,189,69625,044,82724,799,96325,726,12725,620,82124,864,82523,569,87322,937,72923,729,88822,371,91621,688,94121,058,83121,358,88720,590,81619,320,21117,251,82417,578,04317,976,46316,331,28816,877,65416,442,34117,437,34715,622,70215,464,42116,156,94715,897,73115,793,35215,538,11511,334,27110,529,26310,410,6628,632,4968,235,1758,077,5387,878,2687,939,2457,681,0487,302,6057,549,0687,145,0257,131,9536,566,0066,508,7876,643,9815,959,0895,633,7545,463,6034,659,3334,554,8784,602,9094,307,1544,175,6303,855,9143,661,9923,579,1673,374,1303,186,7683,124,3772,979,5912,871,7252,805,7982,923,8132,981,9853,028,6683,000,7722,945,7232,947,0262,733,9792,665,0122,458,3992,465,4562,511,5842,285,7482,163,6352,134,2782,094,1762,118,5232,201,8932,017,2972,189,0811,859,1742,129,2531,779,9461,771,6081,856,1101,856,4391,964,3761,925,6611,791,1221,676,1911,633,2471,588,2911,648,0011,557,8481,631,7291,560,9221,501,5831,510,1241,385,5811,316,7181,105,2461,109,8101,070,857870,122812,789
   > Total Current Assets 
462,397
503,078
631,445
609,815
561,702
740,984
752,229
807,083
771,264
813,000
846,020
823,312
890,497
794,596
878,576
911,739
1,026,232
1,010,486
1,043,551
975,312
976,056
887,778
894,901
1,063,095
845,192
1,161,035
969,016
1,045,776
932,433
878,174
898,672
844,221
948,692
1,203,803
1,138,023
1,156,224
1,331,753
1,401,125
1,605,426
1,586,071
1,701,065
1,695,870
1,645,301
1,609,850
1,521,306
1,591,830
1,711,792
1,841,562
1,890,939
1,988,558
2,098,533
2,155,724
2,319,632
2,629,114
2,650,922
2,907,995
2,624,755
2,461,929
3,008,387
2,973,876
3,171,166
3,407,953
3,097,574
2,980,727
3,484,602
3,230,666
3,559,238
3,165,882
3,506,008
3,639,508
3,476,972
3,577,884
3,771,116
4,180,115
5,934,121
5,970,786
6,867,873
10,998,657
11,305,453
11,349,868
11,511,487
10,628,093
10,761,687
12,471,728
11,404,728
11,890,386
11,300,582
12,873,202
12,364,920
11,915,312
13,854,092
14,627,357
15,408,821
14,258,314
14,629,868
14,673,097
15,807,297
15,013,234
15,612,873
16,987,297
17,868,009
17,927,136
16,984,392
17,266,175
17,178,220
17,506,782
16,613,394
16,419,981
16,465,642
16,465,64216,419,98116,613,39417,506,78217,178,22017,266,17516,984,39217,927,13617,868,00916,987,29715,612,87315,013,23415,807,29714,673,09714,629,86814,258,31415,408,82114,627,35713,854,09211,915,31212,364,92012,873,20211,300,58211,890,38611,404,72812,471,72810,761,68710,628,09311,511,48711,349,86811,305,45310,998,6576,867,8735,970,7865,934,1214,180,1153,771,1163,577,8843,476,9723,639,5083,506,0083,165,8823,559,2383,230,6663,484,6022,980,7273,097,5743,407,9533,171,1662,973,8763,008,3872,461,9292,624,7552,907,9952,650,9222,629,1142,319,6322,155,7242,098,5331,988,5581,890,9391,841,5621,711,7921,591,8301,521,3061,609,8501,645,3011,695,8701,701,0651,586,0711,605,4261,401,1251,331,7531,156,2241,138,0231,203,803948,692844,221898,672878,174932,4331,045,776969,0161,161,035845,1921,063,095894,901887,778976,056975,3121,043,5511,010,4861,026,232911,739878,576794,596890,497823,312846,020813,000771,264807,083752,229740,984561,702609,815631,445503,078462,397
       Cash And Cash Equivalents 
0
50,886
0
37,114
0
89,024
0
76,341
55,038
44,939
60,596
152,526
108,247
110,023
157,399
232,803
247,829
242,364
279,732
295,277
319,564
260,517
262,421
424,072
186,112
482,337
296,052
303,475
202,692
138,770
145,522
129,499
120,414
179,968
131,961
283,852
301,720
293,588
374,333
282,663
380,624
462,971
459,605
540,184
550,054
490,060
572,991
588,532
697,634
718,867
727,363
863,932
998,808
1,272,470
1,211,120
1,447,744
1,147,722
899,778
1,315,919
1,221,333
1,172,683
1,453,195
1,057,071
761,044
1,115,609
757,155
898,949
715,706
801,191
823,127
690,924
798,295
871,982
905,540
2,659,623
2,061,923
3,037,845
6,803,988
6,983,094
7,415,782
7,451,252
6,404,039
6,651,958
8,587,927
7,327,423
7,767,983
7,217,560
8,855,408
8,001,176
7,281,680
9,036,613
9,953,748
10,190,758
8,584,471
8,967,960
9,146,373
9,988,898
9,232,851
9,625,364
10,411,348
10,868,918
10,837,290
10,356,123
11,325,724
11,143,149
11,498,335
10,732,685
10,827,147
10,830,774
10,830,77410,827,14710,732,68511,498,33511,143,14911,325,72410,356,12310,837,29010,868,91810,411,3489,625,3649,232,8519,988,8989,146,3738,967,9608,584,47110,190,7589,953,7489,036,6137,281,6808,001,1768,855,4087,217,5607,767,9837,327,4238,587,9276,651,9586,404,0397,451,2527,415,7826,983,0946,803,9883,037,8452,061,9232,659,623905,540871,982798,295690,924823,127801,191715,706898,949757,1551,115,609761,0441,057,0711,453,1951,172,6831,221,3331,315,919899,7781,147,7221,447,7441,211,1201,272,470998,808863,932727,363718,867697,634588,532572,991490,060550,054540,184459,605462,971380,624282,663374,333293,588301,720283,852131,961179,968120,414129,499145,522138,770202,692303,475296,052482,337186,112424,072262,421260,517319,564295,277279,732242,364247,829232,803157,399110,023108,247152,52660,59644,93955,03876,341089,024037,114050,8860
       Short-term Investments 
0
11,176
0
5,675
0
1,301
0
0
0
0
0
0
0
10,700
10,700
15,955
15,955
14,999
13,955
16,878
20,087
21,622
20,575
60,464
61,345
59,538
58,786
115,108
49,397
73,961
71,588
70,500
109,186
284,843
287,952
137,112
208,081
318,610
442,963
448,101
402,794
248,528
165,486
121,778
38,498
62,172
50,214
48,889
52,215
46,303
52,956
57,866
58,816
56,611
40,473
44,343
48,759
45,284
48,122
59,320
13,882
11,478
9,164
11,335
10,864
10,565
9,562
6,424
6,735
7,025
5,349
6,589
6,430
6,285
5,911
6,019
7,224
6,588
8,825
8,732
20,896
20,776
20,525
15,935
19,699
15,560
15,835
17,192
10,801
13,909
22,243
25,985
170,260
240,934
189,400
182,773
129,305
99,807
121,394
108,094
85,647
90,560
73,180
81,792
87,854
67,942
76,473
89,363
68,320
68,32089,36376,47367,94287,85481,79273,18090,56085,647108,094121,39499,807129,305182,773189,400240,934170,26025,98522,24313,90910,80117,19215,83515,56019,69915,93520,52520,77620,8968,7328,8256,5887,2246,0195,9116,2856,4306,5895,3497,0256,7356,4249,56210,56510,86411,3359,16411,47813,88259,32048,12245,28448,75944,34340,47356,61158,81657,86652,95646,30352,21548,88950,21462,17238,498121,778165,486248,528402,794448,101442,963318,610208,081137,112287,952284,843109,18670,50071,58873,96149,397115,10858,78659,53861,34560,46420,57521,62220,08716,87813,95514,99915,95515,95510,70010,70000000001,30105,675011,1760
       Net Receivables 
0
21,759
0
35,030
0
55,338
0
32,064
35,078
11,132
8,574
11,514
13,379
31,778
174,549
205,644
543,087
202,893
518,724
154,831
123,511
73,996
96,319
390,104
418,112
426,884
438,372
414,446
478,098
438,755
461,835
404,440
466,478
446,416
439,838
449,081
535,271
541,665
528,326
546,534
632,036
695,300
680,810
624,913
635,617
740,813
822,639
885,758
749,480
805,668
887,559
827,791
884,819
916,591
1,001,847
1,035,974
1,047,713
1,089,849
1,185,429
1,199,766
1,465,869
1,397,330
1,457,166
1,606,175
1,675,261
1,690,964
1,846,207
1,648,406
1,853,572
1,928,686
1,886,098
1,856,734
1,944,027
2,294,406
2,247,305
2,113,896
2,407,134
2,822,362
2,894,146
2,698,469
2,760,203
2,938,748
2,880,443
2,630,325
2,912,296
2,945,713
2,836,196
2,703,464
2,964,673
3,055,876
3,285,715
3,108,551
3,578,359
3,928,744
3,967,316
3,622,780
4,001,190
3,843,625
4,035,296
4,285,610
4,534,182
4,584,779
4,271,503
3,648,366
3,775,597
2,347,782
2,146,824
1,935,502
2,001,140
2,001,1401,935,5022,146,8242,347,7823,775,5973,648,3664,271,5034,584,7794,534,1824,285,6104,035,2963,843,6254,001,1903,622,7803,967,3163,928,7443,578,3593,108,5513,285,7153,055,8762,964,6732,703,4642,836,1962,945,7132,912,2962,630,3252,880,4432,938,7482,760,2032,698,4692,894,1462,822,3622,407,1342,113,8962,247,3052,294,4061,944,0271,856,7341,886,0981,928,6861,853,5721,648,4061,846,2071,690,9641,675,2611,606,1751,457,1661,397,3301,465,8691,199,7661,185,4291,089,8491,047,7131,035,9741,001,847916,591884,819827,791887,559805,668749,480885,758822,639740,813635,617624,913680,810695,300632,036546,534528,326541,665535,271449,081439,838446,416466,478404,440461,835438,755478,098414,446438,372426,884418,112390,10496,31973,996123,511154,831518,724202,893543,087205,644174,54931,77813,37911,5148,57411,13235,07832,064055,338035,030021,7590
       Other Current Assets 
462,397
300,362
631,445
356,529
561,702
438,801
752,229
474,812
486,626
535,907
533,537
460,661
478,979
433,007
297,450
259,766
25
324,440
-6
308,993
310,592
340,597
340,570
453
369
369
369
130
33
341
258
870
4,490
4,270
5,621
4,968
-36,485
-31,917
-24,969
-16,635
-18,503
-30,541
-31,063
-23,100
-23,164
-24,443
-26,883
-20,939
-29,741
-34,155
-45,658
-44,079
-41,381
-44,890
-51,230
-44,488
-46,722
-55,639
-59,214
-53,040
-64,795
-47,501
-65,909
-39,477
-56,889
-56,615
-59,357
-52,132
-80,701
-79,298
-70,155
-67,650
-71,776
-61,924
-67,000
689,748
289,601
277,715
307,512
124,263
106,337
110,156
126,318
120,534
102,332
124,468
140,259
128,284
124,793
130,215
125,349
51,277
45,917
42,724
51,355
57,942
51,557
23,411
14,879
136,903
141,240
156,247
141,106
149,642
156,230
55,203
187,632
72,685
166,931
166,93172,685187,63255,203156,230149,642141,106156,247141,240136,90314,87923,41151,55757,94251,35542,72445,91751,277125,349130,215124,793128,284140,259124,468102,332120,534126,318110,156106,337124,263307,512277,715289,601689,748-67,000-61,924-71,776-67,650-70,155-79,298-80,701-52,132-59,357-56,615-56,889-39,477-65,909-47,501-64,795-53,040-59,214-55,639-46,722-44,488-51,230-44,890-41,381-44,079-45,658-34,155-29,741-20,939-26,883-24,443-23,164-23,100-31,063-30,541-18,503-16,635-24,969-31,917-36,4854,9685,6214,2704,49087025834133130369369369453340,570340,597310,592308,993-6324,44025259,766297,450433,007478,979460,661533,537535,907486,626474,812752,229438,801561,702356,529631,445300,362462,397
   > Long-term Assets 
350,392
367,044
439,412
499,994
543,544
575,734
633,352
703,040
730,318
747,923
785,709
734,536
757,504
793,694
754,671
764,452
764,890
915,175
920,825
881,127
880,053
883,830
885,045
1,066,158
1,013,982
1,028,045
1,048,282
1,156,117
1,186,090
1,216,002
1,235,607
1,319,414
1,337,056
1,307,781
1,327,433
1,302,175
1,333,258
1,332,853
1,341,600
1,359,653
1,299,708
1,332,799
1,336,684
1,313,964
1,284,492
1,279,895
1,267,798
1,282,815
1,295,829
1,385,572
1,480,634
1,506,268
1,536,282
1,546,516
1,656,231
1,694,914
1,930,123
2,197,404
2,455,215
2,659,878
2,787,923
3,236,027
3,411,213
3,585,280
3,647,351
3,914,359
3,989,829
4,136,723
4,175,040
4,299,737
4,401,297
4,499,653
4,464,059
4,452,381
4,476,540
4,558,477
4,466,398
4,539,458
4,487,899
4,547,863
4,645,460
4,836,328
4,861,015
4,965,619
5,037,613
4,987,269
5,030,706
5,103,261
5,213,123
5,336,512
5,466,118
5,963,459
5,950,066
6,800,517
7,059,072
7,698,819
7,922,592
7,924,495
7,957,000
7,877,528
7,752,812
7,798,991
7,815,572
7,778,652
8,011,476
8,069,178
8,295,914
8,035,845
8,019,630
8,019,6308,035,8458,295,9148,069,1788,011,4767,778,6527,815,5727,798,9917,752,8127,877,5287,957,0007,924,4957,922,5927,698,8197,059,0726,800,5175,950,0665,963,4595,466,1185,336,5125,213,1235,103,2615,030,7064,987,2695,037,6134,965,6194,861,0154,836,3284,645,4604,547,8634,487,8994,539,4584,466,3984,558,4774,476,5404,452,3814,464,0594,499,6534,401,2974,299,7374,175,0404,136,7233,989,8293,914,3593,647,3513,585,2803,411,2133,236,0272,787,9232,659,8782,455,2152,197,4041,930,1231,694,9141,656,2311,546,5161,536,2821,506,2681,480,6341,385,5721,295,8291,282,8151,267,7981,279,8951,284,4921,313,9641,336,6841,332,7991,299,7081,359,6531,341,6001,332,8531,333,2581,302,1751,327,4331,307,7811,337,0561,319,4141,235,6071,216,0021,186,0901,156,1171,048,2821,028,0451,013,9821,066,158885,045883,830880,053881,127920,825915,175764,890764,452754,671793,694757,504734,536785,709747,923730,318703,040633,352575,734543,544499,994439,412367,044350,392
       Property Plant Equipment 
284,253
303,946
381,499
388,647
428,632
457,323
499,846
514,705
531,128
558,818
593,488
578,306
588,529
587,224
551,586
593,172
595,022
676,371
680,184
663,051
658,997
661,139
666,787
677,521
651,860
659,808
682,139
860,590
878,987
919,705
941,289
1,024,390
1,037,074
1,047,743
1,064,248
1,037,040
1,018,634
989,192
999,608
1,007,881
996,015
988,807
977,690
963,350
949,707
934,916
933,179
928,118
943,694
1,038,657
1,115,274
1,147,044
1,169,930
1,179,954
1,214,698
1,241,945
1,475,916
1,701,887
1,963,492
2,157,678
2,286,266
2,711,645
2,886,637
3,059,811
3,121,850
3,266,639
3,366,916
3,505,407
3,520,552
3,592,507
3,601,522
3,671,087
3,595,816
3,582,998
3,575,155
3,542,712
3,511,041
3,431,785
3,389,623
3,391,497
3,377,911
3,362,302
3,357,986
3,402,095
3,403,150
3,422,414
3,417,249
3,393,586
3,441,696
3,518,350
3,614,359
3,707,090
3,857,659
4,005,654
4,028,187
4,238,892
4,323,760
4,440,747
4,510,055
4,591,886
4,589,415
4,588,491
4,667,658
4,733,895
4,599,478
4,580,711
4,617,388
4,537,255
4,516,793
4,516,7934,537,2554,617,3884,580,7114,599,4784,733,8954,667,6584,588,4914,589,4154,591,8864,510,0554,440,7474,323,7604,238,8924,028,1874,005,6543,857,6593,707,0903,614,3593,518,3503,441,6963,393,5863,417,2493,422,4143,403,1503,402,0953,357,9863,362,3023,377,9113,391,4973,389,6233,431,7853,511,0413,542,7123,575,1553,582,9983,595,8163,671,0873,601,5223,592,5073,520,5523,505,4073,366,9163,266,6393,121,8503,059,8112,886,6372,711,6452,286,2662,157,6781,963,4921,701,8871,475,9161,241,9451,214,6981,179,9541,169,9301,147,0441,115,2741,038,657943,694928,118933,179934,916949,707963,350977,690988,807996,0151,007,881999,608989,1921,018,6341,037,0401,064,2481,047,7431,037,0741,024,390941,289919,705878,987860,590682,139659,808651,860677,521666,787661,139658,997663,051680,184676,371595,022593,172551,586587,224588,529578,306593,488558,818531,128514,705499,846457,323428,632388,647381,499303,946284,253
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65,488
65,488
65,488
67,179
67,179
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
103,040
124,911
124,911
124,911
124,911
124,911
124,911
124,911
124,911
124,911
124,911124,911124,911124,911124,911124,911124,911124,911124,911103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,040103,04067,17967,17965,48865,48865,488000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
508,065
550,890
595,813
637,124
563,788
609,207
651,237
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000651,237609,207563,788637,124595,813550,890508,065000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
2,960
0
4,457
0
5,747
0
8,060
7,844
28,461
34,430
36,741
42,661
58,437
65,070
72,953
72,068
113,005
116,679
109,022
106,642
108,915
105,634
108,276
109,079
110,499
107,284
122,391
119,918
118,136
118,306
117,294
125,273
124,065
130,041
136,903
158,992
156,875
155,873
156,102
155,342
160,203
158,150
158,406
155,352
154,209
152,552
153,629
156,002
156,039
175,203
168,104
175,701
175,077
174,317
171,896
169,928
209,359
205,551
206,640
202,003
226,816
227,690
224,516
221,707
257,246
253,133
258,276
254,040
261,918
269,400
272,727
261,343
289,297
307,070
313,725
307,549
299,995
296,351
289,133
299,943
328,997
312,636
325,340
330,632
348,398
357,696
378,064
389,995
422,453
457,412
487,820
505,396
514,897
530,431
834,779
917,589
941,249
941,736
826,392
723,463
740,513
691,748
714,172
721,092
725,926
716,249
624,180
644,093
644,093624,180716,249725,926721,092714,172691,748740,513723,463826,392941,736941,249917,589834,779530,431514,897505,396487,820457,412422,453389,995378,064357,696348,398330,632325,340312,636328,997299,943289,133296,351299,995307,549313,725307,070289,297261,343272,727269,400261,918254,040258,276253,133257,246221,707224,516227,690226,816202,003206,640205,551209,359169,928171,896174,317175,077175,701168,104175,203156,039156,002153,629152,552154,209155,352158,406158,150160,203155,342156,102155,873156,875158,992136,903130,041124,065125,273117,294118,306118,136119,918122,391107,284110,499109,079108,276105,634108,915106,642109,022116,679113,00572,06872,95365,07058,43742,66136,74134,43028,4617,8448,06005,74704,45702,9600
       Long-term Assets Other 
66,139
60,138
57,912
106,890
114,911
112,654
133,507
180,275
191,346
160,644
157,791
119,488
126,314
121,999
48,728
47,678
-675
63,528
46,198
45,358
63,940
66,422
66,566
205,390
201,761
200,900
203,321
123,087
120,688
118,652
116,005
113,000
110,146
69,905
67,704
65,503
214,214
325,237
449,562
455,953
409,857
255,884
172,432
127,420
44,159
67,471
55,387
54,350
58,205
53,568
59,950
66,506
66,652
65,077
49,084
58,613
64,774
60,499
62,648
77,105
32,834
29,919
25,606
25,250
25,471
25,226
22,366
31,993
35,600
44,104
98,906
106,519
123,268
126,674
124,821
213,515
189,173
328,105
267,997
359,587
664,193
424,041
414,499
413,668
446,745
425,936
415,893
411,866
374,105
384,394
396,124
465,176
599,154
705,700
753,583
757,304
706,641
518,363
515,778
445,542
424,849
433,028
444,749
222,879
686,047
438,318
658,362
589,613
576,489
576,489589,613658,362438,318686,047222,879444,749433,028424,849445,542515,778518,363706,641757,304753,583705,700599,154465,176396,124384,394374,105411,866415,893425,936446,745413,668414,499424,041664,193359,587267,997328,105189,173213,515124,821126,674123,268106,51998,90644,10435,60031,99322,36625,22625,47125,25025,60629,91932,83477,10562,64860,49964,77458,61349,08465,07766,65266,50659,95053,56858,20554,35055,38767,47144,159127,420172,432255,884409,857455,953449,562325,237214,21465,50367,70469,905110,146113,000116,005118,652120,688123,087203,321200,900201,761205,39066,56666,42263,94045,35846,19863,528-67547,67848,728121,999126,314119,488157,791160,644191,346180,275133,507112,654114,911106,89057,91260,13866,139
> Total Liabilities 
235,890
246,649
389,906
447,494
399,838
547,096
455,252
473,432
443,923
494,506
518,289
583,952
646,239
581,237
628,908
639,371
728,246
801,390
798,551
727,052
724,709
632,283
631,088
954,696
669,553
1,001,638
828,959
1,029,966
912,904
899,562
922,399
925,200
1,013,494
1,214,461
1,143,267
1,079,873
1,099,303
1,045,129
1,031,704
954,798
1,002,629
1,174,748
1,137,067
1,089,289
886,968
846,362
890,202
898,918
828,155
928,931
1,031,343
1,022,841
1,075,242
1,343,452
1,414,953
1,591,291
1,430,961
1,567,264
2,383,899
2,453,635
2,630,122
3,295,097
3,028,183
2,961,487
3,320,800
3,277,567
3,556,772
3,220,184
3,175,486
3,305,893
3,288,149
3,267,641
3,209,443
3,477,095
3,601,366
3,423,624
3,939,147
8,049,127
4,563,316
4,664,107
4,675,826
4,596,333
4,044,584
5,687,470
4,364,307
5,303,419
4,391,205
5,701,226
4,794,828
4,716,913
6,202,774
6,950,734
7,227,952
7,605,040
7,700,969
8,060,891
8,799,314
8,950,902
9,058,494
9,928,574
10,204,667
11,476,302
10,331,727
10,008,754
9,750,195
10,968,561
9,973,518
9,550,079
9,109,970
9,109,9709,550,0799,973,51810,968,5619,750,19510,008,75410,331,72711,476,30210,204,6679,928,5749,058,4948,950,9028,799,3148,060,8917,700,9697,605,0407,227,9526,950,7346,202,7744,716,9134,794,8285,701,2264,391,2055,303,4194,364,3075,687,4704,044,5844,596,3334,675,8264,664,1074,563,3168,049,1273,939,1473,423,6243,601,3663,477,0953,209,4433,267,6413,288,1493,305,8933,175,4863,220,1843,556,7723,277,5673,320,8002,961,4873,028,1833,295,0972,630,1222,453,6352,383,8991,567,2641,430,9611,591,2911,414,9531,343,4521,075,2421,022,8411,031,343928,931828,155898,918890,202846,362886,9681,089,2891,137,0671,174,7481,002,629954,7981,031,7041,045,1291,099,3031,079,8731,143,2671,214,4611,013,494925,200922,399899,562912,9041,029,966828,9591,001,638669,553954,696631,088632,283724,709727,052798,551801,390728,246639,371628,908581,237646,239583,952518,289494,506443,923473,432455,252547,096399,838447,494389,906246,649235,890
   > Total Current Liabilities 
233,390
246,499
389,606
447,194
399,538
464,937
373,093
388,744
363,492
461,984
461,709
525,087
585,638
530,717
578,388
638,821
726,359
728,490
725,651
644,614
641,852
595,945
594,450
896,394
648,409
981,494
812,300
919,695
801,928
788,992
812,529
907,949
992,296
1,163,308
1,052,185
947,091
956,508
903,720
918,924
836,453
901,787
1,115,817
1,081,532
967,374
763,365
722,226
778,127
777,207
705,237
792,168
896,465
925,214
1,028,307
1,306,409
1,374,139
1,521,046
1,359,703
1,505,975
2,320,671
2,376,186
2,404,778
2,674,477
2,407,151
2,329,681
2,694,164
2,651,545
2,930,119
2,669,170
2,688,342
3,211,592
3,188,631
3,154,940
3,101,854
3,370,602
3,483,429
3,310,641
3,829,546
7,942,237
4,444,295
4,411,031
4,426,179
4,341,836
3,788,353
5,369,578
4,049,478
4,979,567
4,060,381
5,293,657
4,392,168
4,302,323
5,797,121
6,082,889
6,400,792
6,485,769
6,572,330
6,925,068
6,614,783
6,751,508
6,734,018
7,396,665
7,357,541
8,238,881
7,300,888
8,087,137
8,329,920
9,697,273
9,013,265
7,625,428
7,235,300
7,235,3007,625,4289,013,2659,697,2738,329,9208,087,1377,300,8888,238,8817,357,5417,396,6656,734,0186,751,5086,614,7836,925,0686,572,3306,485,7696,400,7926,082,8895,797,1214,302,3234,392,1685,293,6574,060,3814,979,5674,049,4785,369,5783,788,3534,341,8364,426,1794,411,0314,444,2957,942,2373,829,5463,310,6413,483,4293,370,6023,101,8543,154,9403,188,6313,211,5922,688,3422,669,1702,930,1192,651,5452,694,1642,329,6812,407,1512,674,4772,404,7782,376,1862,320,6711,505,9751,359,7031,521,0461,374,1391,306,4091,028,307925,214896,465792,168705,237777,207778,127722,226763,365967,3741,081,5321,115,817901,787836,453918,924903,720956,508947,0911,052,1851,163,308992,296907,949812,529788,992801,928919,695812,300981,494648,409896,394594,450595,945641,852644,614725,651728,490726,359638,821578,388530,717585,638525,087461,709461,984363,492388,744373,093464,937399,538447,194389,606246,499233,390
       Short-term Debt 
0
109,713
0
200,818
0
230,723
0
108,379
158,386
199,496
153,496
139,521
122,010
173,790
172,990
301,620
364,120
325,620
232,320
183,167
155,620
81,470
56,600
492,500
316,208
670,926
485,926
448,816
391,066
382,068
496,739
594,099
629,981
836,835
698,531
580,688
537,767
535,612
537,153
420,412
482,281
661,603
630,533
531,115
291,105
252,444
304,880
219,012
221,573
259,217
245,480
277,860
406,230
208,464
208,332
251,725
251,703
376,407
538,686
536,570
496,410
493,117
682,331
491,484
841,394
685,108
678,031
376,320
377,713
1,146,873
850,400
650,400
650,400
860,400
350,400
400
400
400
400
400
150,400
272,487
400
1,500,400
400
400
400
1,360,841
275,580
270,884
1,470,884
1,559,482
1,664,245
1,771,953
1,864,574
2,052,332
1,417,740
1,619,716
1,722,876
1,632,681
1,813,522
1,624,783
1,573,658
3,414,277
2,699,875
0
0
0
0
00002,699,8753,414,2771,573,6581,624,7831,813,5221,632,6811,722,8761,619,7161,417,7402,052,3321,864,5741,771,9531,664,2451,559,4821,470,884270,884275,5801,360,8414004004001,500,400400272,487150,400400400400400400350,400860,400650,400650,400850,4001,146,873377,713376,320678,031685,108841,394491,484682,331493,117496,410536,570538,686376,407251,703251,725208,332208,464406,230277,860245,480259,217221,573219,012304,880252,444291,105531,115630,533661,603482,281420,412537,153535,612537,767580,688698,531836,835629,981594,099496,739382,068391,066448,816485,926670,926316,208492,50056,60081,470155,620183,167232,320325,620364,120301,620172,990173,790122,010139,521153,496199,496158,386108,3790230,7230200,8180109,7130
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
400
400
400
833,271
400
1,360,841
275,580
270,884
1,470,884
1,550,943
1,658,059
1,761,920
1,854,753
2,043,048
1,405,808
1,607,775
1,711,608
1,622,240
1,800,000
1,610,000
1,560,009
1,860,010
1,360,010
1,850,000
2,050,000
2,455,000
2,325,000
2,325,0002,455,0002,050,0001,850,0001,360,0101,860,0101,560,0091,610,0001,800,0001,622,2401,711,6081,607,7751,405,8082,043,0481,854,7531,761,9201,658,0591,550,9431,470,884270,884275,5801,360,841400833,271400400400400000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
43,410
0
121,303
0
93,261
0
125,290
48,916
94,354
105,425
96,425
156,789
141,827
147,597
112,110
122,617
147,021
250,785
228,374
219,710
264,294
285,168
134,149
142,095
130,813
133,324
258,177
246,979
217,433
155,653
159,343
218,045
189,891
189,923
185,310
226,366
174,465
161,101
181,559
176,866
192,889
164,260
159,487
188,475
156,077
124,847
182,395
171,943
191,712
236,388
164,678
123,338
180,249
179,321
207,941
246,477
390,059
511,665
595,395
667,708
742,476
755,207
811,742
898,637
900,260
918,330
951,369
992,352
1,014,147
901,391
935,760
881,613
919,916
920,028
911,511
1,052,826
1,193,815
1,159,068
1,163,527
1,266,676
1,317,866
1,301,570
1,354,915
1,485,006
1,482,004
1,270,484
1,263,090
1,357,683
1,346,714
1,470,406
1,624,794
1,741,341
1,861,780
1,688,972
1,817,300
1,953,170
1,908,780
1,731,887
1,862,022
1,921,231
1,919,519
1,800,898
763,825
1,784,371
1,714,824
1,716,917
1,583,979
1,538,918
1,538,9181,583,9791,716,9171,714,8241,784,371763,8251,800,8981,919,5191,921,2311,862,0221,731,8871,908,7801,953,1701,817,3001,688,9721,861,7801,741,3411,624,7941,470,4061,346,7141,357,6831,263,0901,270,4841,482,0041,485,0061,354,9151,301,5701,317,8661,266,6761,163,5271,159,0681,193,8151,052,826911,511920,028919,916881,613935,760901,3911,014,147992,352951,369918,330900,260898,637811,742755,207742,476667,708595,395511,665390,059246,477207,941179,321180,249123,338164,678236,388191,712171,943182,395124,847156,077188,475159,487164,260192,889176,866181,559161,101174,465226,366185,310189,923189,891218,045159,343155,653217,433246,979258,177133,324130,813142,095134,149285,168264,294219,710228,374250,785147,021122,617112,110147,597141,827156,78996,425105,42594,35448,916125,290093,2610121,303043,4100
       Other Current Liabilities 
233,390
3,007
389,606
716
399,538
12,323
373,093
10,278
727
20,952
13,835
15,304
12,099
15,804
17,041
24,354
21,204
30,548
37,624
18,281
30,210
24,181
5,602
18,717
19,987
13,544
14,550
15,299
9,292
7,353
9,273
8,513
10,778
6,409
6,051
7,567
11,507
9,391
7,631
5,050
8,774
8,935
4,209
12,803
11,823
7,749
8,272
16,482
12,105
10,309
11,385
21,127
16,923
418,033
419,875
439,029
225,638
31,032
428,301
437,950
437,731
447,349
55,415
61,780
97,251
49,916
348,384
356,014
366,766
40,181
276,687
65,255
51,837
54,439
407,843
428,685
815,618
4,567,500
66,247
115,289
73,481
400
400
400
400
400
400
151,765
154,580
110,630
2,575,511
6,267
4,754
4,755
3,344
13,485
3,243,873
3,223,012
3,235,287
3,675,777
3,558,905
88,715
44,284
3,771,037
45,173
11,415
11,322
10,642
3,642
3,64210,64211,32211,41545,1733,771,03744,28488,7153,558,9053,675,7773,235,2873,223,0123,243,87313,4853,3444,7554,7546,2672,575,511110,630154,580151,76540040040040040040073,481115,28966,2474,567,500815,618428,685407,84354,43951,83765,255276,68740,181366,766356,014348,38449,91697,25161,78055,415447,349437,731437,950428,30131,032225,638439,029419,875418,03316,92321,12711,38510,30912,10516,4828,2727,74911,82312,8034,2098,9358,7745,0507,6319,39111,5077,5676,0516,40910,7788,5139,2737,3539,29215,29914,55013,54419,98718,7175,60224,18130,21018,28137,62430,54821,20424,35417,04115,80412,09915,30413,83520,95272710,278373,09312,323399,538716389,6063,007233,390
   > Long-term Liabilities 
2,500
150
300
300
300
82,159
82,159
84,688
80,431
32,522
56,580
58,864
60,601
50,520
50,520
550
1,887
72,900
72,900
82,438
82,858
36,338
36,638
58,301
21,144
20,144
16,659
110,270
110,976
110,570
109,870
17,250
21,198
51,153
91,083
132,781
142,795
141,409
112,780
118,345
100,842
58,932
55,535
121,915
123,603
124,136
112,075
121,711
122,918
136,763
134,878
97,627
46,935
37,043
40,815
70,245
71,258
61,289
63,229
77,449
225,344
620,620
621,032
631,806
626,636
626,021
626,652
551,013
487,144
94,300
99,518
112,701
107,589
106,492
117,937
112,983
109,601
106,890
119,022
253,077
249,647
254,497
256,230
317,892
314,829
323,851
330,824
407,568
402,661
414,589
405,653
867,845
827,159
1,119,271
1,128,639
1,135,823
2,184,531
2,199,395
2,324,477
2,531,909
2,847,126
3,237,421
3,030,839
1,921,616
1,420,275
1,271,288
960,253
1,924,651
1,874,671
1,874,6711,924,651960,2531,271,2881,420,2751,921,6163,030,8393,237,4212,847,1262,531,9092,324,4772,199,3952,184,5311,135,8231,128,6391,119,271827,159867,845405,653414,589402,661407,568330,824323,851314,829317,892256,230254,497249,647253,077119,022106,890109,601112,983117,937106,492107,589112,70199,51894,300487,144551,013626,652626,021626,636631,806621,032620,620225,34477,44963,22961,28971,25870,24540,81537,04346,93597,627134,878136,763122,918121,711112,075124,136123,603121,91555,53558,932100,842118,345112,780141,409142,795132,78191,08351,15321,19817,250109,870110,570110,976110,27016,65920,14421,14458,30136,63836,33882,85882,43872,90072,9001,88755050,52050,52060,60158,86456,58032,52280,43184,68882,15982,1593003003001502,500
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
3,943
0
0
1
1,337
0
0
10,937
11,358
11,338
11,638
33,302
21,144
20,144
16,659
20,681
20,886
21,481
20,880
16,551
20,498
20,453
20,382
22,082
22,670
15,961
13,725
15,256
15,118
16,220
14,285
19,300
20,670
20,279
28,744
27,658
28,999
0
27,807
0
43,532
33,740
37,811
67,143
68,102
57,987
59,785
74,173
71,859
67,244
68,305
79,072
74,578
74,142
75,436
77,272
79,107
84,701
88,577
99,559
94,210
90,606
101,823
94,998
90,934
84,092
95,044
225,844
221,274
253,797
255,530
317,192
314,129
323,851
330,824
407,568
402,661
414,589
405,653
497,422
457,364
473,730
484,497
493,768
547,750
527,242
537,976
0
610,838
604,546
593,130
0
0
0
0
0
0
000000593,130604,546610,8380537,976527,242547,750493,768484,497473,730457,364497,422405,653414,589402,661407,568330,824323,851314,129317,192255,530253,797221,274225,84495,04484,09290,93494,998101,82390,60694,21099,55988,57784,70179,10777,27275,43674,14274,57879,07268,30567,24471,85974,17359,78557,98768,10267,14337,81133,74043,532027,807028,99927,65828,74420,27920,67019,30014,28516,22015,11815,25613,72515,96122,67022,08220,38220,45320,49816,55120,88021,48120,88620,68116,65920,14421,14433,30211,63811,33811,35810,937001,3371003,943000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
152,437
173,486
194,493
202,425
229,358
246,820
259,845
272,989
299,070
338,169
373,491
390,651
377,597
397,150
704,410
745,025
768,834
780,084
0
284,501
392,903
430,429
0
0
0
0
0
0
000000430,429392,903284,5010780,084768,834745,025704,410397,150377,597390,651373,491338,169299,070272,989259,845246,820229,358202,425194,493173,486152,437000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
576,899
618,262
675,765
657,096
700,215
738,535
898,668
994,194
1,016,288
1,018,649
1,043,717
901,998
910,856
916,002
908,286
918,972
940,208
963,177
988,341
949,409
972,306
993,820
1,004,608
1,044,558
1,097,849
1,092,905
1,114,019
1,139,715
1,172,173
1,163,803
1,178,612
1,204,386
1,241,090
1,264,179
1,286,329
1,339,527
1,524,104
1,650,276
1,871,321
1,942,664
1,953,864
1,804,951
1,795,865
1,778,536
1,855,727
1,953,366
2,015,968
2,149,085
2,274,883
2,342,705
2,429,435
2,517,438
2,640,632
2,706,180
2,759,694
2,843,170
2,959,206
2,924,778
2,917,554
3,008,016
3,154,805
3,117,420
3,237,077
3,344,649
3,487,063
3,484,689
3,610,288
3,696,517
4,110,133
4,238,203
4,184,314
4,346,255
4,580,995
4,668,742
6,302,916
6,505,987
6,785,993
6,857,403
10,585,261
10,772,740
11,079,098
10,377,013
10,702,321
10,651,977
11,030,242
10,533,459
10,860,270
11,166,752
11,610,840
11,096,584
11,600,080
12,107,242
12,518,509
12,001,203
12,532,011
13,003,764
13,561,769
12,866,920
13,432,828
13,876,021
14,284,902
13,413,384
13,642,436
14,042,495
14,606,162
13,919,888
14,158,595
13,862,334
14,165,649
14,165,64913,862,33414,158,59513,919,88814,606,16214,042,49513,642,43613,413,38414,284,90213,876,02113,432,82812,866,92013,561,76913,003,76412,532,01112,001,20312,518,50912,107,24211,600,08011,096,58411,610,84011,166,75210,860,27010,533,45911,030,24210,651,97710,702,32110,377,01311,079,09810,772,74010,585,2616,857,4036,785,9936,505,9876,302,9164,668,7424,580,9954,346,2554,184,3144,238,2034,110,1333,696,5173,610,2883,484,6893,487,0633,344,6493,237,0773,117,4203,154,8053,008,0162,917,5542,924,7782,959,2062,843,1702,759,6942,706,1802,640,6322,517,4382,429,4352,342,7052,274,8832,149,0852,015,9681,953,3661,855,7271,778,5361,795,8651,804,9511,953,8641,942,6641,871,3211,650,2761,524,1041,339,5271,286,3291,264,1791,241,0901,204,3861,178,6121,163,8031,172,1731,139,7151,114,0191,092,9051,097,8491,044,5581,004,608993,820972,306949,409988,341963,177940,208918,972908,286916,002910,856901,9981,043,7171,018,6491,016,288994,194898,668738,535700,215657,096675,765618,262576,899
   Common Stock
184,422
184,422
0
199,422
199,422
199,422
227,010
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
306,035
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
295,722
304,382
304,382
395,697
396,890
396,890
396,890
425,730
425,730
425,597
425,563
553,231
553,231
553,231
719,050
719,050
719,050
719,050
719,048
934,763
934,763
935,657
940,773
943,585
944,835
939,096
935,754
937,491
937,865
938,248
934,958
935,131
935,553
935,553
935,553
935,553
923,938
926,645
0
0
0
0
0000926,645923,938935,553935,553935,553935,553935,131934,958938,248937,865937,491935,754939,096944,835943,585940,773935,657934,763934,763719,048719,050719,050719,050719,050553,231553,231553,231425,563425,597425,730425,730396,890396,890396,890395,697304,382304,382295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722295,722306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035306,035227,010199,422199,422199,4220184,422184,422
   Retained Earnings 
69,143
115,655
0
5,466
48,586
58,401
83,973
84,319
106,693
97,600
122,668
39,159
45,722
50,794
43,407
18,974
40,211
58,050
83,048
16,166
39,063
50,984
69,290
70,826
40,222
118,779
138,536
118,519
149,775
140,735
71,619
153,523
182,896
214,782
238,736
267,810
314,114
546,490
764,099
817,303
817,303
725,381
664,285
711,151
827,871
929,145
681,290
1,114,710
1,114,710
1,311,832
1,070,352
1,446,715
1,446,715
1,638,075
1,417,213
1,740,646
1,740,646
1,821,490
1,936,416
2,023,349
2,023,349
2,134,798
2,254,223
2,352,112
2,495,463
2,495,185
2,627,561
2,707,954
2,890,605
3,018,359
3,172,968
3,267,019
3,497,131
3,477,636
3,683,348
3,812,412
4,087,423
4,103,633
7,845,873
8,028,315
8,384,032
7,563,791
7,870,541
8,012,612
8,405,387
7,890,998
8,191,888
8,419,003
8,818,362
8,348,769
8,765,573
8,937,313
9,621,792
9,003,194
9,393,448
9,716,401
10,269,695
9,518,594
10,007,848
10,437,636
11,019,545
10,089,057
10,556,041
10,908,186
11,516,010
10,830,059
11,347,751
11,761,379
12,398,087
12,398,08711,761,37911,347,75110,830,05911,516,01010,908,18610,556,04110,089,05711,019,54510,437,63610,007,8489,518,59410,269,6959,716,4019,393,4489,003,1949,621,7928,937,3138,765,5738,348,7698,818,3628,419,0038,191,8887,890,9988,405,3878,012,6127,870,5417,563,7918,384,0328,028,3157,845,8734,103,6334,087,4233,812,4123,683,3483,477,6363,497,1313,267,0193,172,9683,018,3592,890,6052,707,9542,627,5612,495,1852,495,4632,352,1122,254,2232,134,7982,023,3492,023,3491,936,4161,821,4901,740,6461,740,6461,417,2131,638,0751,446,7151,446,7151,070,3521,311,8321,114,7101,114,710681,290929,145827,871711,151664,285725,381817,303817,303764,099546,490314,114267,810238,736214,782182,896153,52371,619140,735149,775118,519138,536118,77940,22270,82669,29050,98439,06316,16683,04858,05040,21118,97443,40750,79445,72239,159122,66897,600106,69384,31983,97358,40148,5865,4660115,65569,143
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000-7,283-7,283-66,787-66,787-75,162-75,162-137,660-140,322-152,048-157,075-247,220-247,220-218,2420000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
323,334
318,186
0
452,207
452,207
480,711
587,686
603,839
603,559
615,013
615,013
556,804
559,099
559,173
558,843
593,962
593,962
599,092
599,257
627,207
627,207
636,800
629,283
667,697
751,591
668,091
669,448
715,161
716,362
717,032
800,958
744,828
752,158
743,361
741,558
765,682
903,954
797,751
801,187
819,326
830,525
773,534
825,544
761,349
721,821
718,186
1,028,643
738,653
864,451
735,151
1,063,361
775,001
898,195
772,384
1,046,759
806,802
922,838
807,566
685,416
688,945
835,735
686,900
687,132
696,814
695,878
693,781
687,006
692,840
915,145
915,461
615,649
682,347
686,975
794,216
2,193,838
2,267,845
2,272,973
2,328,207
2,186,157
2,191,193
2,141,834
2,094,172
2,112,729
1,920,316
1,905,806
1,923,413
1,733,620
1,812,987
1,856,821
1,807,042
1,890,922
2,225,093
1,957,621
2,062,255
2,201,072
2,349,497
2,353,826
1,386,441
1,745,048
1,366,393
-177,799
1,223,203
-402,091
1,029,948
-128,432
0
0
0
0
0000-128,4321,029,948-402,0911,223,203-177,7991,366,3931,745,0481,386,4412,353,8262,349,4972,201,0722,062,2551,957,6212,225,0931,890,9221,807,0421,856,8211,812,9871,733,6201,923,4131,905,8061,920,3162,112,7292,094,1722,141,8342,191,1932,186,1572,328,2072,272,9732,267,8452,193,838794,216686,975682,347615,649915,461915,145692,840687,006693,781695,878696,814687,132686,900835,735688,945685,416807,566922,838806,8021,046,759772,384898,195775,0011,063,361735,151864,451738,6531,028,643718,186721,821761,349825,544773,534830,525819,326801,187797,751903,954765,682741,558743,361752,158744,828800,958717,032716,362715,161669,448668,091751,591667,697629,283636,800627,207627,207599,257599,092593,962593,962558,843559,173559,099556,804615,013615,013603,559603,839587,686480,711452,207452,2070318,186323,334



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue11,812,339
Cost of Revenue-4,081,107
Gross Profit7,731,2327,731,232
 
Operating Income (+$)
Gross Profit7,731,232
Operating Expense-8,982,215
Operating Income2,830,124-1,250,983
 
Operating Expense (+$)
Research Development1,033,356
Selling General Administrative2,971,299
Selling And Marketing Expenses0
Operating Expense8,982,2154,004,655
 
Net Interest Income (+$)
Interest Income247,957
Interest Expense-88,607
Other Finance Cost-4,404
Net Interest Income154,946
 
Pretax Income (+$)
Operating Income2,830,124
Net Interest Income154,946
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,806,1462,830,124
EBIT - interestExpense = -88,607
2,061,096
2,149,702
Interest Expense88,607
Earnings Before Interest and Taxes (EBIT)02,894,753
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,806,146
Tax Provision-501,661
Net Income From Continuing Ops2,304,4852,304,485
Net Income2,061,096
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-154,946
 

Technical Analysis of Livzon
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Livzon. The general trend of Livzon is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Livzon's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Livzon Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Livzon Pharmaceutical Group Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 38.03.

The bearish price targets are: 34.78 > 31.00 > 30.87.

Know someone who trades $000513? Share this with them.👇

Livzon Pharmaceutical Group Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Livzon Pharmaceutical Group Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Livzon Pharmaceutical Group Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Livzon Pharmaceutical Group Inc. The current macd is 1.81271622.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Livzon price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Livzon. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Livzon price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Livzon Pharmaceutical Group Inc Daily Moving Average Convergence/Divergence (MACD) ChartLivzon Pharmaceutical Group Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Livzon Pharmaceutical Group Inc. The current adx is 46.16.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Livzon shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Livzon Pharmaceutical Group Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Livzon Pharmaceutical Group Inc. The current sar is 35.20.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Livzon Pharmaceutical Group Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Livzon Pharmaceutical Group Inc. The current rsi is 68.17. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Livzon Pharmaceutical Group Inc Daily Relative Strength Index (RSI) ChartLivzon Pharmaceutical Group Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Livzon Pharmaceutical Group Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Livzon price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Livzon Pharmaceutical Group Inc Daily Stochastic Oscillator ChartLivzon Pharmaceutical Group Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Livzon Pharmaceutical Group Inc. The current cci is 56.89.

Livzon Pharmaceutical Group Inc Daily Commodity Channel Index (CCI) ChartLivzon Pharmaceutical Group Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Livzon Pharmaceutical Group Inc. The current cmo is 33.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Livzon Pharmaceutical Group Inc Daily Chande Momentum Oscillator (CMO) ChartLivzon Pharmaceutical Group Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Livzon Pharmaceutical Group Inc. The current willr is -27.73489216.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Livzon is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Livzon Pharmaceutical Group Inc Daily Williams %R ChartLivzon Pharmaceutical Group Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Livzon Pharmaceutical Group Inc.

Livzon Pharmaceutical Group Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Livzon Pharmaceutical Group Inc. The current atr is 0.94656644.

Livzon Pharmaceutical Group Inc Daily Average True Range (ATR) ChartLivzon Pharmaceutical Group Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Livzon Pharmaceutical Group Inc. The current obv is 116,551,367.

Livzon Pharmaceutical Group Inc Daily On-Balance Volume (OBV) ChartLivzon Pharmaceutical Group Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Livzon Pharmaceutical Group Inc. The current mfi is 37.73.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Livzon Pharmaceutical Group Inc Daily Money Flow Index (MFI) ChartLivzon Pharmaceutical Group Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Livzon Pharmaceutical Group Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Livzon Pharmaceutical Group Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Livzon Pharmaceutical Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.168
Ma 20Greater thanMa 5033.680
Ma 50Greater thanMa 10030.339
Ma 100Greater thanMa 20029.201
OpenGreater thanClose36.340
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Livzon with someone you think should read this too:
  • Are you bullish or bearish on Livzon? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Livzon? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Livzon Pharmaceutical Group Inc

I send you an email if I find something interesting about Livzon Pharmaceutical Group Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Livzon Pharmaceutical Group Inc.

Receive notifications about Livzon Pharmaceutical Group Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.